Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • torrent

    Tag: torrent

    You Searched For "torrent"
    SEBI exempts Trust from making open offers for Torrent Group Companies

    SEBI exempts Trust from making open offers for Torrent Group Companies

    MD bureau15 Jan 2020 10:00 AM IST
    The trust currently does not hold any shares in these three firms. Pursuant to the scheme of amalgamation, the trust will hold over 71.2 per cent...
    Revenue from operations stood at Rs 2005 crore in Q2: Torrent Pharma

    Revenue from operations stood at Rs 2005 crore in Q2: Torrent Pharma

    Medical Dialogues Bureau2 Nov 2019 9:15 AM IST
    Consolidated revenue from operations stood at Rs 2,005 crore for the quarter under consideration as against Rs 1,894 crore for the same period last...
    Torrent Pharma shares slump 3pc on USFDA warning letter for Gujarat facility

    Torrent Pharma shares slump 3pc on USFDA warning letter for Gujarat facility

    Medical Dialogues Bureau11 Oct 2019 9:15 AM IST
    Torrent Pharma does not believe that the warning letter will have an impact on the disruption of supplies or the existing revenues from operations of...
    DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5

    DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5

    Meghna A Singhania6 May 2019 11:23 AM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Torrent Pharma gets USFDA observations for Dahej plant

    Torrent Pharma gets USFDA observations for Dahej plant

    Farhat Nasim9 April 2019 9:30 AM IST
    Torrent Pharma announced that the audit at Dahej plant in Gujarat was carried out by US Food and Drug Administration (USFDA) in March 2019. New Delhi:...
    Torrent completes acquisition of branded business of Unichem Labs

    Torrent completes acquisition of branded business of Unichem Labs

    Ruby Khatun Khatun16 Dec 2017 3:58 PM IST
    New Delhi: Torrent Pharmaceuticals said it has completed the Rs 3,600 crore acquisition of Unichem's branded business for India and Nepal.The...
    Indian Pharma companies biggest violators of USFDA integrity norms

    Indian Pharma companies biggest violators of USFDA integrity norms

    Geeta Sharma Sharma7 May 2016 3:35 PM IST
    Mumbai:Sixty percent of reported data integrity violations in the records of US regulator since 2011 are against drug manufacturing units in...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok